Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug development optimization--benzodiazepines.

M Lader

    Agents and Actions. Supplements
    |January 1, 1990
    PubMed
    Summary
    This summary is machine-generated.

    Benzodiazepines are widely used, but can cause persistent cognitive issues and serious side effects like falls. Discontinuation leads to withdrawal syndromes, with shorter-acting drugs causing more severe symptoms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A patient who changed my practice: Personality disorder or bipolar disorder?

    International journal of psychiatry in clinical practice·2014
    Same author

    Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal.

    European psychiatry : the journal of the Association of European Psychiatrists·2012
    Same author

    Plasma concentrations of tricyclic antidepressive drugs.

    British journal of clinical pharmacology·2012
    Same author

    Caffeine withdrawal symptoms and rate of metabolism.

    Journal of psychopharmacology (Oxford, England)·2012
    Same author

    Buspirone treatment as an aid to benzodiazepine withdrawal.

    Journal of psychopharmacology (Oxford, England)·2012
    Same author

    A comparison of augmenting central serotonin and noradrenaline function in healthy subjects: implications for studies on the neurochemistry of anxiety.

    Journal of psychopharmacology (Oxford, England)·2012
    Same journal

    Ro 45-2081, a TNF receptor fusion protein, prevents inflammatory responses in the airways.

    Agents and actions. Supplements·1998
    Same journal

    Immunomodulation of Crohn's disease by interleukin-10.

    Agents and actions. Supplements·1998
    Same journal

    Cartilage protective agent (CPA) Ro 32-3555, a new matrix metalloproteinase inhibitor for the treatment of rheumatoid arthritis.

    Agents and actions. Supplements·1998
    Same journal

    Symposium new drugs for inflammatory, allergic and immunologic disease.

    Agents and actions. Supplements·1998
    Same journal

    The complexity of the B7-CD28/CTLA-4 costimulatory pathway.

    Agents and actions. Supplements·1998
    Same journal

    A role for inflammatory cytokines in the productive activation of antigen-specific CD4+ T-cells.

    Agents and actions. Supplements·1998
    See all related articles

    Area of Science:

    • Pharmacology
    • Psychiatry
    • Geriatrics

    Background:

    • Benzodiazepines are frequently prescribed medications with common sedative effects.
    • Cognitive impairment and risks such as falls in the elderly are significant practical concerns.
    • Drug discontinuation can precipitate withdrawal, rebound, and relapse syndromes.

    Purpose of the Study:

    • To review the clinical implications of benzodiazepine use and discontinuation.
    • To highlight the prevalence and consequences of chronic benzodiazepine use.
    • To discuss the varying characteristics and newer developments in benzodiazepine pharmacology.

    Main Methods:

    • Literature review of benzodiazepine effects, usage patterns, and discontinuation syndromes.
    • Analysis of epidemiological data on chronic benzodiazepine use in different countries.

    Related Experiment Videos

  • Examination of pharmacokinetic and pharmacodynamic properties of various benzodiazepine compounds.

    • Main Results:

    • Sedative effects may diminish, but cognitive deficits can persist.
    • Withdrawal syndromes, particularly perceptual hypersensitivity, are common and distressing, exacerbated by shorter-acting agents.
    • Chronic use prevalence varies significantly across populations, with higher rates in some European countries and the USA.

    Conclusions:

    • Benzodiazepine use carries risks, especially concerning cognitive function and elderly safety.
    • Discontinuation requires careful management due to potential withdrawal symptoms.
    • Understanding drug properties like half-life and potency is crucial for safe prescribing and managing newer agents.